James Hussey

James Hussey has a diverse work experience spanning over several years. James is currently the Chief Executive Officer of Seneca Therapeutics, Inc. since August 2020. Prior to that, they worked as the President of James Hussey Consulting from November 2019 to August 2020. From July 2018 to November 2019, they served as the Special Advisor to the Chairman/Acting US President at MorphoSys AG. Their previous roles include Executive Vice President at Athenex from May 2016 to May 2018, Consultant at Self-employed from April 2015 to April 2016, President at Sagent Pharmaceuticals from March 2013 to March 2015, Chief Executive Officer at NanoInk, Inc. from January 2008 to February 2013, VP Strategic Planning at Ovation Pharmaceuticals from June 2005 to January 2008, Chief Executive Officer at NeoPharm, Inc. from March 1998 to June 2004, and Chief Executive Officer at Physicians Quality Care from September 1994 to March 1998.

James Hussey obtained a Bachelor of Science degree in Pharmacy from Butler University, attending from 1977 to 1982. James then pursued a Master's in Business Administration, specializing in Business, from the University of Illinois Chicago, attending from 1982 to 1984. In addition to their educational background, they hold a certification as a Registered Pharmacist from the Indiana Board of Pharmacy.